Paricalcitol: all 90 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Paricalcitol Versus Pirfenidone for Improving Surgical Resectability in Patients With Peritoneal CancerNot yet recruitingNCT07856914Phase 2
- The Impact of Selective Vitamin D Receptor Activation on Clinical Outcomes in Septic PatientsNot yet recruitingNCT06209268Not applicable
- Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic CancerCompletedNCT04524702Phase 2Results posted
- A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)TerminatedNCT04064827Phase 3Results posted
- A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic CancerTerminatedNCT03519308Early Phase 1Results posted
- Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)CompletedNCT03415854Phase 2Results posted
- A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic CancerCompletedNCT03331562Phase 2Results posted
- Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal AdenocarcinomaCompletedNCT02754726Phase 2Results posted
- Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.CompletedNCT01939977Phase 4Results posted
- Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. ParicalcitolTerminatedNCT01725113Phase 4Results posted
- A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant PatientsCompletedNCT01506947Phase 4Results posted
- A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or HemodialysisCompletedNCT01382212Phase 3Results posted
- Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary HyperparathyroidismCompletedNCT01341782Phase 3Results posted
- Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant PatientsCompletedNCT01265615Phase 4Results posted
- The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration RateCompletedNCT01163162Phase 4Results posted
- Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass SurgeryCompletedNCT01138475Phase 3Results posted
- Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyroid Hormone in Chronic Kidney DiseaseCompletedNCT01071070Phase 3Results posted
- Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)CompletedNCT01020487Phase 3Results posted
- Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney DiseaseTerminatedNCT01012414Phase 3Results posted
- Metabolic Effects of ParicalcitolCompletedNCT01003275Phase 2Results posted
- Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary HyperparathyroidismCompletedNCT00990704Phase 2Results posted
- Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin DCompletedNCT00977080Phase 4Results posted
- Vascular Reactivity in Chronic Kidney Disease (CKD) Patients Receiving Paricalcitol Versus PlaceboCompletedNCT00915876Not applicableResults posted
- Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial DoseCompletedNCT00891813Phase 4Results posted
- Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)CompletedNCT00823303Phase 4Results posted
- Vitamin D and Coronary Calcification StudyCompletedNCT00752102Phase 4Results posted
- Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)CompletedNCT00701805Phase 2Results posted
- Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving HemodialysisCompletedNCT00667576Phase 2Results posted
- Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis SubjectsTerminatedNCT00664430Phase 4Results posted
- Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone MetastasesTerminatedNCT00634582Phase 2Results posted
- The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5TerminatedNCT00616902Phase 3Results posted
- Oral Paricalcitol in Kidney Transplant RecipientsCompletedNCT00587158Not applicableResults posted
- Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on DialysisCompletedNCT00537979Phase 4Results posted
- The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4CompletedNCT00497146Phase 3Results posted
- Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on InflammationCompletedNCT00428246Not applicableResults posted
- The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System InhibitorsCompletedNCT00421733Phase 2Results posted
- Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic RicketsCompletedNCT00417612Phase 3Results posted
- A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney DiseaseCompletedNCT00257920Phase 4Results posted
- A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitisActive, not recruitingNCT05664880Early Phase 1
- PHL Treatment in Pancreatic CancerActive, not recruitingNCT05365893Early Phase 1
- A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary HyperparathyroidismStatus unknownNCT04994080Phase 3
- Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic CancerCompletedNCT04617067Phase 2
- Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based TherapyCompletedNCT03883919Phase 1
- Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic CancerTerminatedNCT03520790Phase 1
- A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic CancerTerminatedNCT03300921Phase 1
- Intravenous Paricalcitol in Chronic Hemodialysis PatientsStatus unknownNCT03023748Phase 4
- Paricalcitol Improves Anemia of InflammationTerminatedNCT02876211Phase 4
- DBPC-Dose-finding-trial of Vitamin D3 for SCIT in Birch Pollen Allergic Patients.CompletedNCT02686827Phase 2
- Effect of Paricalcitol Over Vessel WallTerminatedNCT02372695Phase 4
- Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting ConditionsCompletedNCT02322632Phase 1
- Paricalcitol in Fabry DiseaseCompletedNCT02090608Not applicable
- A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic CancerCompletedNCT02030860Phase 1
- Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease PatientsCompletedNCT01820767Phase 3
- Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney DiseaseStatus unknownNCT01792206Not applicable
- Paricalcitol Effect on Anemia in CKDCompletedNCT01768351Phase 4
- Oral Paricalcitol in Renal Transplant Recipients for Reducing AlbuminuriaCompletedNCT01694160Phase 3
- The Effects of Active VItamin D on Left Atrial Volume IndexWithdrawnNCT01630408Not applicable
- Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin DStatus unknownNCT01442272Phase 4
- Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant RecipientsCompletedNCT01436747Phase 3
- Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 DiabetesCompletedNCT01393808Phase 2
- Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic NephropathyCompletedNCT01331317Phase 4
- Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary HyperparathyroidismCompletedNCT01220050Phase 2
- Vitamin-D Receptor Activation (VDRA) in Chronic Kidney DiseaseCompletedNCT01204528Phase 2/3
- Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in SurgeryTerminatedNCT01197664Phase 1
- Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney DiseaseCompletedNCT01136564Phase 2
- Vitamin D Deficiency in Chronic Kidney Disease (CKD) PatientsCompletedNCT00958451Phase 4
- Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary HyperparathyroidismCompletedNCT00800358Not applicable
- Oral Paricalcitol in Stage 3 - 5 Chronic Kidney DiseaseCompletedNCT00796679Not applicable
- Immune Effects of Vitamin D in Hemodialysis PatientsCompletedNCT00686751Phase 2
- Paricalcitol Injection Phase II TrialCompletedNCT00646932Phase 2
- Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast CancerCompletedNCT00637897Phase 1
- Paricalcitol for the Treatment of Immunoglobulin A NephropathyWithdrawnNCT00599963Phase 3
- A Study Of Oral Paricalcitol To Treat Proteinuric Renal DiseaseWithdrawnNCT00469625Not applicable
- Treatment of Secondary Hyperparathyroidism in the Uremic PatientTerminatedNCT00469599Not applicable
- A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® InjectionCompletedNCT00463021Phase 4
- A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on HemodialysisCompletedNCT00454350Phase 4
- Initial Dosing of Paricalcitol in Secondary HyperparathyroidismCompletedNCT00307840Phase 4
- Effect of Paricalcitol on Markers of Inflammation in Hemodialysis PatientsCompletedNCT00294866Phase 4
- Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell DisordersTerminatedNCT00258258Phase 1
- Paricalcitol and Gemcitabine in Treating Patients With Advanced CancerCompletedNCT00217477Phase 1
- Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal DialysisCompletedNCT00091975Phase 3
- Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on HemodialysisCompletedNCT00091481Phase 4
- Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of CalciumCompletedNCT00073710Phase 4
- Paricalcitol in Treating Patients With Myelodysplastic SyndromeCompletedNCT00064376Phase 2
- Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on HemodialysisTerminatedNCT00062699Phase 4
- Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on HemodialysisCompletedNCT00053547Phase 4
- A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU SubjectsCompletedNCT00053378Phase 2
- Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)CompletedNCT00048516Phase 3
- Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)CompletedNCT00048451Phase 3
- Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)CompletedNCT00048438Phase 3